| REVIEW ARTICLE |
|
| Year : 2013 | Volume
: 3
| Issue : 2 | Page : 143-151 |
|
|
Prophylaxis and treatment of venous thromboembolism in the critically ill
Sarah M Adriance, Claire V Murphy
Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus OH, USA
Correspondence Address:
Sarah M Adriance
Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 W. 10th Ave, 368 Doan Hall, Columbus, OH
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2229-5151.114274
|
|
|
Venous thromboembolism (VTE) is a frequent complication in critically ill patients and is associated with increased rates of morbidity and mortality. The use of thromboprophylaxis to reduce the risk of VTE in this patient population is the standard of care. This review will summarize the recommendations set forth in consensus guidelines for the prevention and treatment of VTE across subgroups within the critically ill patient population. In addition, the drug properties of the recommended pharmacologic agents for thromboprophylaxis will be highlighted including their pharmacokinetics, dosing and complications. The critical care practitioner may also encounter novel oral anticoagulants with increasing frequency. These agents will be briefly reviewed in terms of their approved and investigational indications and the clinical concerns related to their use will also be discussed. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
